For the nine months ended September 30, 2021, we had a net income of $17,044,620, which consists of the interest earned on marketable securities held in Trust Account of $82,072 and the change in the fair value of warrant liability of $21,656,844, offset by operational costs of $4,694,296.
For the three months ended September 30, 2020, we had a net loss of $817,071, which consists of formation and operational costs of $121,555 and transaction costs associated with the Initial Public Offering of $715,720, offset by interest earned on marketable securities held in Trust Account of $20,204.
For the period from May 29, 2020 (inception) through September 30, 2020, we had a net loss of $818,071, which consists of formation and operational costs of $122,555 and transaction costs associated with the Initial Public Offering of $715,720, offset by interest earned on marketable securities held in Trust Account of $20,204.
Liquidity and Capital Resources
On September 9, 2020, we consummated the Initial Public Offering of 33,421,570 Units at a price of $10.00 per Unit, which includes the partial exercise by the underwriter of its over-allotment option in the amount of 3,421,570 Units, generating gross proceeds of $334,215,700. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 9,700,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $9,700,000.
Following the Initial Public Offering, the partial exercise of the over-allotment option by the underwriter’s and the sale of the Private Placement Warrants, a total of $334,215,700 was placed in the Trust Account. We incurred $18,847,894 in transaction costs, including $6,684,314 of underwriting fees, $11,697,550 of deferred underwriting fees and $466,030 of other offering costs.
For the nine months ended September 30, 2021, cash used in operating activities was $1,535,361. Net income of $17,044,620 was affected by change in fair value of warrant liabilities of $21,656,844 and interest earned on marketable securities held in the Trust Account of $82,072. Changes in operating assets and liabilities provided $3,158,935 of cash for operating activities.
For the period from May 29, 2020 (inception) through September 30, 2020, cash used in operating activities was $392,481. Net loss of $818,071 was affected by the transaction costs associated with the Initial Public Offering of $715,720 and interest earned on marketable securities held in Trust Account of $20,204. Changes in operating assets and liabilities used $269,926 of cash from operating activities.
As of September 30, 2021, we had marketable securities and cash held in the Trust Account of $334,403,203. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account to complete our Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of September 30, 2021, we had $693,437 of cash held outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay the Working Capital Loans out of the proceeds of the Trust Account released to us. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, we may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants, at a price of $1.00 per warrant, of the post Business Combination entity. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans.